Taurine, a darling of longevity seekers, is found to be unreliable biomarker for aging
A study shows levels of the amino acid taurine rise rather than fall over time, confounding the goal of dietary supplements popular in anti-aging circles.
Related Articles
Do you remember the Human Genome Project? I’m not sure the Trump administration wants you to
The NIH archives of the Human Genome Project could fall victim to Trump administration cuts, writes a former archivist.
RFK Jr. acknowledges receiving unproven stem cell treatment from an Antigua clinic
RFK Jr.’s admission raises new concerns about a possible upcoming wave of reckless stem cell deregulation from this administration.
RFK Jr. acknowledges receiving unproven stem cell treatment from an Antigua clinic
RFK Jr.’s admission raises new concerns about a possible upcoming wave of reckless stem cell deregulation from this administration.
FDA reassures rare disease advocates that ‘being flexible’ is plan for gene therapy
Trump health officials signal eased FDA rules for rare disease gene therapy, but concerns linger over safety, oversight, and speed of new drug approvals.
Dismantling CDC’s chronic disease center ‘looks pretty devastating’ to public health experts
HHS plans to fold the CDC’s chronic disease center into the new Administration for a Healthy America. Experts fear for coordination with local health departments,…
NIH details how Trump budget would cut support for grants, training, and research centers
President Trump’s 2026 budget proposes cutting NIH grants to universities, academic medical centers, and other institutions by 43%
NIH details how Trump budget would cut support for grants, training, and research centers
President Trump’s 2026 budget proposes cutting NIH grants to universities, academic medical centers, and other institutions by 43%
BridgeBio CEO: Congress must renew a popular, bipartisan FDA program benefiting sick kids
In Washington, even widely hailed programs with bipartisan support — like the rare pediatric disease priority review voucher program — are falling by the wayside,…
An AI experiment at the FDA & Novo trailing in the obesity drug race
This week on “The Readout LOUD” podcast: an AI experiment at the FDA and how Novo Nordisk is trailing in the obesity drug race.
RFK Jr. acknowledges receiving unproven stem cell treatment from an Antigua clinic
RFK Jr.’s admission raises new concerns about a possible upcoming wave of reckless stem cell deregulation from this administration.